Retinal Microglia: Revealing New Opportunities for Identifying Early Biomarkers of Diabetic Retinopathy

Ohisa Harley1,2, Yufilia Suci Amelia2, Elsa Gustianty2,3,4

  • 1Doctoral Program in Medical Sciences, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia.

Current Eye Research
|June 24, 2025
PubMed
Abstract

Insights

Microglia, the retina's immune cells, drive inflammation in diabetic retinopathy (DR) through pathways like NLRP3 inflammasome activation. Understanding this neuroinflammation is key for early DR detection and new treatments.

Area of Science:

  • Ophthalmology
  • Immunology
  • Neuroscience

Background:

  • Diabetic retinopathy (DR) is a complication of diabetes characterized by retinal inflammation.
  • Identifying reliable inflammatory biomarkers for DR detection remains challenging.
  • Microglia, the resident immune cells in the retina, are implicated in neuroinflammation.
  • Prolonged hyperglycemia can trigger inflammatory responses in the retina.

Purpose of the Study:

  • To investigate the role of microglia in the inflammatory mechanisms of diabetic retinopathy (DR).
  • To explore the inflammatory perspective of microglial involvement in DR pathogenesis.

Main Methods:

  • Systematic literature search across multiple scientific databases.
  • Collection, summarization, and synthesis of relevant research articles.

Main Results:

  • Hyperglycemia may lead to excessive extracellular adenosine triphosphate (eATP) release.
  • eATP can overstimulate P2X7R receptors, activating the NLRP3 inflammasome.
  • This activation results in chronic progressive inflammation within the retina.

Conclusions:

  • Microglial activation and polarization contribute to meta-inflammation in DR.
  • This process increases retinal permeability and neovascularization, leading to proliferative DR.
  • Understanding microglial pathways is crucial for developing early DR detection biomarkers and adjunctive therapies.